发明名称 Treatment of myelosuppression
摘要 Methods are presented for attenuating myelosuppressive side effects of treatment regimens, promoting thrombopoiesis and neutrophil production, and increasing efficacy of treatment regimens, by administering PF4-interacting heparinoids.
申请公布号 US9271999(B2) 申请公布日期 2016.03.01
申请号 US201313801990 申请日期 2013.03.13
申请人 Cantex Pharmaceuticals, Inc. 发明人 Marcus Stephen
分类号 A61K31/727;A61K35/28;A61K39/395;A61N5/00;A61K45/06 主分类号 A61K31/727
代理机构 Fenwick & West LLP 代理人 Fenwick & West LLP
主权项 1. A method of treating thrombocytopenia other than heparin-induced thrombocytopenia, comprising: administering a substantially non-anticoagulating PF4-interacting heparinoid to a subject with thrombocytopenia other than heparin-induced thrombocytopenia in an amount effective to promote thrombopoiesis.
地址 Weston FL US